Use of pulmonary surfactant

Details Use of pulmonary surfactant Use of pulmonary surfactant

2006-01-03

2006-01-03

Wax, Robert A. (Department: 1653)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C514S012200

Reexamination Certificate

active

06982075

ABSTRACT:
The invention describes the novel use of pulmonary surfactant preparations in the artificial respiration of patents with toxic oxygen concentrations.

REFERENCES:
patent: 251449 (1967-01-01), None
patent: 32 29 179 (1984-02-01), None
patent: 0 100 910 (1984-02-01), None
patent: 0 110 498 (1984-06-01), None
patent: 0 119 056 (1984-09-01), None
patent: 0 145 005 (1985-06-01), None
patent: 0 251 449 (1988-01-01), None
patent: 0 286 011 (1988-10-01), None
patent: 0 348 967 (1990-01-01), None
patent: 0 368 823 (1990-05-01), None
patent: 0 406 732 (1991-01-01), None
patent: 0 593 094 (1994-04-01), None
patent: 86/03408 (1986-06-01), None
patent: 87/06943 (1987-11-01), None
patent: 88/03170 (1988-05-01), None
patent: 89/04326 (1989-05-01), None
patent: 91/00871 (1991-01-01), None
patent: 91/18015 (1991-11-01), None
patent: 92/22315 (1992-12-01), None
patent: 95/32992 (1995-12-01), None
patent: 97/26863 (1997-07-01), None
patent: 97/35882 (1997-10-01), None
patent: 98/49191 (1998-11-01), None
patent: 01/58423 (2001-08-01), None
Ghio, A.J. et al. “Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury”,Surfactant, Oxidants, and Hyperoxic Lung Injury, American Physiological Society, vol. 77 (3) pp. 1217-1223, 1994.
Goerke, Jon “Lung Surfactant”,Biochimica at Biophysica Acta, Elsevier Scientific Publishing Company, vol. 344 pp. 241-261, 1974.
Gommers, D. et al. “Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS)”,Intensive Care Med, vol. 24 pp. 494-500, 1998.
Häfner, D. et al. “Effects of rSP-C Surfactant on Oxygenation and Histology in a Rat-Lung-Lavage Model of Acute Lung Injury”,Am J Respir Crit Care Med, vol. 158 pp. 270-278, 1998.
Häfner, D. et al. “Additive Effects on Phosphodiesterase-4 Inhibition on Effects of rSP-C Surfactant”,Am J Respir Crit Care Med, vol. 161 pp. 1495-1500, 2000.
King, R.J. et al. “Physiological Correlations”,Am J Physiol, vol. 223 pp. 714-726, 1972.
Lodato, R.F. “Oxygen Toxicity”,Critical Care Clinics, vol. 6 (3) pp. 749-765, 1990.
Possmayer, F. et al. “Calcium-Protein-Lipid Interactions in Pulmonary Surfactant”,Prog. Resp. Res., vol. 18 pp. 112-120, 1984.
Tokieda, K. et al. “Surfactant Protein-B-Deficient Mice Are Susceptible to Hyperoxic Lung Injury”,Am. J. Respir. Cell Mol. Biol., vol. 21 pp. 463-472, 1999.

Affiliated with

Also associated with

Rating

Use of pulmonary surfactant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pulmonary surfactant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pulmonary surfactant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3572464